Maternal Ezetimibe Concentrations Measured in Breast Milk and Its Use in Breastfeeding Infant Exposure Predictions

Cindy H. T. Yeung,Julie Autmizguine,Pooja Dalvi,Audrey Denoncourt,Shinya Ito,Pamela Katz,Mehzabin Rahman,Yves Theoret,Andrea N. Edginton
DOI: https://doi.org/10.1007/s40262-023-01345-0
2024-01-27
Clinical Pharmacokinetics
Abstract:Lactating mothers taking ezetimibe, an antihyperlipidemic agent, may be hesitant to breastfeed despite the known benefit of breastfeeding to both mother and infant. Currently, no data exist on the presence or concentration of ezetimibe and its main active metabolite, ezetimibe-glucuronide (EZE-glucuronide), in human breast milk.
pharmacology & pharmacy
What problem does this paper attempt to address?